期刊文献+

新一代广谱氟喹诺酮类抗菌药物吉米沙星 被引量:17

A novel broad-spectrum fluoroquinolone gemifloxacin
下载PDF
导出
摘要 吉米沙星是韩国LG Life Science公司研制的第四代氟喹诺酮类抗菌新药,它同时作用于细菌DNA旋转酶和DNA拓扑异构酶IV,提高了抗菌活性,降低耐药率。吉米沙星除了保持对革兰阴性菌的强大抗菌活性外,对包括多重耐药性肺炎链球菌在内的革兰阳性菌也具有良好的活性。吉米沙星具有良好的药动学性质,组织渗透性强,能强力杀灭感染部位致病菌。它的药物间相互作用少,有较好的安全性和耐受性,是临床上治疗慢性支气管炎急性发作、社区获得性肺炎和急性鼻窦炎的良好药物。 Gemifloxacin is a novel, broad-spectrum fluoroquinolone. This review summarized the mechanism of action, antibacterial activity, pharmacokinetic, pharmacokinetic/pharmacodynamic, adverse effect and therapeutic effect of gemifloxacin.
作者 李然 王睿
出处 《中国抗生素杂志》 CAS CSCD 北大核心 2008年第8期453-460,共8页 Chinese Journal of Antibiotics
关键词 吉米沙星 氟喹诺酮 抗菌作用 药动学 临床疗效 Gemifloxacin Fluoroquinolone Antibacterial activity Pharmacokinetic Therapeutic effect
  • 相关文献

参考文献32

  • 1周伟澄,周后元.氟喹诺酮类抗菌药物研究进展[J].中国医药工业杂志,2005,36(5):309-312. 被引量:18
  • 2Lowe M N, Lamb H M. Gemifloxacin [J]. Drugs,2000, 59(5):1137-1147.
  • 3王秀云,刘明亮.吉米沙星在治疗社区获得性下呼吸道感染中的作用[J].国外医药(抗生素分册),2005,26(6):259-267. 被引量:3
  • 4Rittenhouse S, McCloskey L, Broskey J, et al. In vitro antibacterial activity of gemifloxacin and comparator compounds against common respiratory pathogens [J]. J Antirnicrob Chemother, 2000,45 (Suppl 1 ) : 23 - 27.
  • 5Felmingham D, Grunebery R N. The Alexander project 2000, European surveillance data [J]. J Antimicrob Chemother, 2001,47 (Suppl 2) : 24- 25.
  • 6McCloskey L, Moore T, Niconovich N, et al. In vitro activity of gemifloxaein against a broad range of recent clinical isolates from the USA [J].J Antimicrob Chemother,2000,45(Suppl 1):13-21.
  • 7Marchese A, Debbia E A, Schito G C. Comparative in vitro potency of gemifloxacin against European respiratory tract pathogens isolated in the Alexander Project [J]. J Antimicrob Chemother, 2000,46 (Suppl T1 ) : 11 - 15.
  • 8Doern G V, Heilmann K P, Huynh H K, et al. Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999 - 2000, including a comparison of resistance rates since 19941995 [J]. Antimicrob Agents Chemother,2001,45(6) :1721-1729.
  • 9Davies T A, Kelly L M, Pankuch G A, et al. Antipneumococcal activities of gemifloxaein compared to those of nine other agents [J]. Antimicrob Agents Chemother, 2000,44(2) : 304- 310.
  • 10King A, May J, French G, et al. Comparative in vitro activity of gemifloxaein [J]. J Antimicrob Chemother, 2000,45(Suppl 1) :1-12.

二级参考文献62

  • 1尹玉琴,蒋思强,田梅兰,邹静,徐贵丽.消可治与阿米卡星,妥布霉素的体外抗生素后效应研究[J].药学实践杂志,2000,18(6):370-371. 被引量:8
  • 2周伟澄,张秀平.氟喹诺酮类药物研究的新进展[J].中国医药工业杂志,1997,28(2):75-81. 被引量:35
  • 3Vogelman B, Gudmyndsson S, et al. In vivo PAE in a thigh intection in neutro penic mice. J Infect Dis, 1998, 157(2) :287.
  • 4Lass- Florl C, Direich MP, Fuchs D. Antifungal properties of selective serotonin reuptake inhibitors against Aspergillus species in vitro. J Antimicrob Chemother, 2001,48(6) :775.
  • 5MacKenzie FM, Milne KE, Gould IM. Calculation of composite recovery time: a new pharmaeyodymamic parameter. J Antimicrob Chemother, 2002, 50(2) :281.
  • 6Omri A, Suntres ZE, Shek PN . Enhanced activity of liposomal polymyxin B against Pseudomonas aeruginosa in a rat model of lung infection. Bioehem Phannaeol, 2002, 64 (9) : 1407.
  • 7Pastos A , Canton E , Peman J . Relationship between the sensitivity of Pseudom onas aeruginosa and the postantibiotic effect of sparlloxacin and ciprofloxacin . Rev Esp Quimioter, 1998, 11(4) :333.
  • 8Pankuch GA , Jacobs MR , Appelbaum PC. Postantibiotic elects of gatifloxacin gram - positive and negative organisms. J Anfimicrob Chemother, 1999,42(10) :2574.
  • 9Pendland SL, Neubauser MM, Prause JL. In vitro bactericidal activity and postantibiatic effect of ABT - 773 versus co - amoxiclav against anaerobes . J Antimicrob Chemother, 2002, 49 (5) :879.
  • 10Boswell FJ , Andrews JM, Wise R. Bactericidal properties of moxifloxacin and postantibiotic effect . J Antimicrob Chemother,1999, 4 3(1) :43.

共引文献81

同被引文献129

引证文献17

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部